Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
11
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Guzman Pablo A. | Chief Medical Officer | 2 | $0 | $0 | 2025-07-11 |
| Park Min-Chul | Director | 4 | $0 | $0 | 2025-07-11 |
| Cashmere Karen A. | Director | 7 | $0 | $0 | 2025-07-11 |
| Wolfe Peter | Chief Financial Officer | 11 | $0 | $0 | 2025-07-11 |
| SAPIRSTEIN JAMES | Director | 2 | $0 | $0 | 2025-07-11 |
| Finizio Robert G | Director | 5 | $0 | $0 | 2025-07-11 |
| Freitag Gregory Gene | Director | 2 | $0 | $0 | 2025-07-11 |
| Glover Stephen C. | Chief Executive Officer | 16 | $0 | $0 | 2025-07-11 |
| INCON Co., Ltd. | 10% Owner | 2 | $0 | $0 | 2022-12-12 |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | 8 | $0 | $0 | 2022-12-12 |
| O'Connor Daniel J. | Director, 10% Owner | 4 | $0 | $0 | 2022-12-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| SAPIRSTEIN JAMES | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| Park Min-Chul | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 60,100 | — | $0 | 60,100 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| Guzman Pablo A. | Chief Medical Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 48,900 | — | $0 | 48,900 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2025-07-11 | 2025-07-15 | 136,900 | — | $0 | 136,900 | SEC↗ |
| Finizio Robert G | Director | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2025-07-11 | 2025-07-16 | 48,100 | — | $0 | 48,100 | SEC↗ |
| Park Min-Chul | Director | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| Cashmere Karen A. | Director | A Award deriv | 2023-05-24 | 2024-07-18 | 572 | — | $0 | 572 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2023-05-24 | 2024-07-18 | 715 | — | $0 | 715 | SEC↗ |
| Freitag Gregory Gene | Director | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2023-05-24 | 2024-07-18 | 1,627 | — | $0 | 1,627 | SEC↗ |
| Finizio Robert G | Director | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| SAPIRSTEIN JAMES | Director | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| Guzman Pablo A. | Chief Medical Officer | A Award deriv | 2023-01-26 | 2023-01-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award | 2022-12-16 | 2022-12-20 | 3,000 | $2.88 | $8.6K | 44,585 | SEC↗ |
| O'Connor Daniel J. | Director, 10% Owner | J Other deriv | 2022-12-12 | 2022-12-14 | 177,204 | — | $0 | 177,204 | SEC↗ |
| O'Connor Daniel J. | Director, 10% Owner | J Other deriv | 2022-12-12 | 2022-12-14 | 1,750 | — | $0 | 1,750 | SEC↗ |
| O'Connor Daniel J. | Director, 10% Owner | J Other deriv | 2022-12-12 | 2022-12-14 | 1,750 | — | $0 | 1,750 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 168,761 | — | $0 | 168,761 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 18 | — | $0 | 1,750 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 138,980 | — | $0 | 138,980 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 1,750 | — | $0 | 1,750 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 264,838 | — | $0 | 264,838 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 126,138 | — | $0 | 126,138 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 17,903 | — | $0 | 17,903 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 3,022 | — | $0 | 3,022 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 70,881 | — | $0 | 70,881 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 79,417 | — | $0 | 79,417 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 21,840 | — | $0 | 21,840 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 19,854 | — | $0 | 19,854 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| Cashmere Karen A. | Chief Commercial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 21,840 | — | $0 | 21,840 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 39,708 | — | $0 | 39,708 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 59,563 | — | $0 | 59,563 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 39,709 | — | $0 | 39,709 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 19,854 | — | $0 | 19,854 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 18,094 | — | $0 | 18,094 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| Park Min-Chul | Director | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| Park Min-Chul | Director | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 21,840 | — | $0 | 21,840 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 11,763 | — | $0 | 11,763 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 18,058 | — | $0 | 18,058 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 21,840 | — | $0 | 21,840 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 39,708 | — | $0 | 39,708 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| Finizio Robert G | Director | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| Finizio Robert G | Director | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| Finizio Robert G | Director | A Award deriv | 2022-12-12 | 2022-12-14 | 19,854 | — | $0 | 19,854 | SEC↗ |
| INCON Co., Ltd. | 10% Owner | A Award deriv | 2022-12-12 | 2022-12-16 | 450,702 | — | $0 | 450,702 | SEC↗ |
| O'Connor Daniel J. | Director, 10% Owner | J Other | 2022-12-12 | 2022-12-14 | 1,377,598 | — | $0 | 1,377,598 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award | 2022-12-12 | 2022-12-14 | 43,847 | — | $0 | 43,847 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award | 2022-12-12 | 2022-12-14 | 448,909 | — | $0 | 448,909 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award | 2022-12-12 | 2022-12-14 | 85,442 | — | $0 | 85,442 | SEC↗ |
| Glover Stephen C. | Chief Executive Officer | A Award | 2022-12-12 | 2022-12-14 | 49,636 | — | $0 | 49,636 | SEC↗ |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | A Award | 2022-12-12 | 2022-12-14 | 18,094 | — | $0 | 18,094 | SEC↗ |
| Wolfe Peter | Chief Financial Officer | A Award | 2022-12-12 | 2022-12-14 | 41,585 | — | $0 | 41,585 | SEC↗ |
| INCON Co., Ltd. | 10% Owner | A Award | 2022-12-12 | 2022-12-16 | 1,497,199 | — | $0 | 1,497,199 | SEC↗ |